The U.S. Food and Drug Administration (FDA) issued a Safety Communication today reminding consumers and health care providers that currently authorized SARS-CoV-2 antibody tests should not be used to evaluate a person’s level of immunity or protection from COVID-19.
SARS-CoV-2 antibody tests help identify whether someone has antibodies to SARS-CoV-2, the beta coronavirus that causes COVID-19, indicating a prior virus infection.
The FDA stated on May 19, 2021, these antibody test results can be misinterpreted, especially after the person received a COVID-19 vaccination.
mRNA COVID-19 Vaccine Antibody Test Results Require Professional Interpretation
Frequency of Autoantibody-Negative Type 1 Diabetes in Children, Adolescents, and Young Adults During the First Wave of the COVID-19 Pandemic in Germany.
The aim of this study was to investigate the frequency of newly diagnosed type 1 diabetes without evidence of autoimmunity and the respective frequencies of ketoacidosis in children, adolescents, and […]
Converting to a Synchronous Virtual Nursing Research Conference Amidst a Pandemic: A Case Study.
University of California San Diego Health was set to launch its 13th annual Nursing and Inquiry Innovation Conference event in June 2020. However, the Coronavirus Disease 2019 (COVID-19) pandemic placed […]
Limits of remote working: the ethical challenges in conducting Mental Health Act assessments during COVID-19.
COVID-19 has created additional challenges in mental health services, including the impact of social distancing measures on care and treatment. For situations where a detention under mental health legislation is […]
Multisystemic inflammatory syndrome in a young adult after SARS-CoV2 infection: case report.
SARS-CoV-2 infection may precede the appearance of dysregulated immune responses adopting form of multisystemic inflammatory syndrome in adults (MIS-A), that can be fatal because of end-organ damage. We present a […]
Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?
Since the beginning of the COVID-19 pandemic, reduced incidence of many viral and bacterial infections has been reported in children: bronchiolitis, varicella, measles, pertussis, pneumococcal and meningococcal invasive diseases. The […]
The perception of training and professional development according to nursing students as health workers during COVID-19: A qualitative study.
To explore the perception of education and professional development of final-year nursing students who carried out health relief tasks during the COVID-19 pandemic.The COVID-19 pandemic has led to a global […]
Don't Hesitate, Early Monoclonal Treatment Advised for Certain COVID-19 Patients
A COVID-19 treatment that is given early after coronavirus infection cuts the risk of hospitalization and death by 60% in those patients most likely to suffer complications of the disease, according to an analysis of 232 University of Pittsburgh Medical Center (UPMC) patients.
Venous Thromboembolic Event Rates Up With ChAdOx1-S Vaccine
However, absolute risks are small, with 11 excess venous thromboembolic events per 100,000 vaccinations
Fully Vaccinated Travelers Can Soon Visit EU Countries
New measures for tourists and other travelers could take effect as early as next week
- Page 1 of 2
- 1
- 2